Updated Date:
22 Oct 2026
Product Detail:
DBL CYTARABINE 1g/10mL injection vial
Shortage Status:
Anticipated
AUST R:
47284
Availability:
Available
Active Ingredient:
cytarabine
Reason:
Unexpected increase in consumer demand
Dosage Form:
Injection,solution
Supply Impact Dates
From 28 Apr 2027
To 30 Jun 2028
Management Action:
The sponsor is closely controlling the supply. Overseas-registered products with the same active ingredient has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals